FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768609580> ?p ?o ?g. }

• W2768609580 abstract "The present study investigated the mechanism underlying Toll-like receptor 4 (TLR4)-mediated stimulation of hypoxia-inducible factor-1α (HIF-1α) activity and its association with reactive oxygen species (ROS) in cervical cancer cells. SiHa cells were cultured and randomized to control, lipopolysaccharide (LPS), methyl-β-cyclodextrin (MβCD)+LPS, ammonium pyrrolidinedithiocarbamate (PDTC)+LPS, ST2825+LPS and small interfering (si) RNA TLR4+LPS treatment groups. Cell proliferation was quantified using an MTT assay, cell cloning was performed using soft agar colony formation and HIF-1α expression was detected by immunocytochemical staining and western blot analyses. Dichloro-dihydro-fluorescein diacetate and lucigenin luminescence assays were used to detect alterations in ROS and nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase content, respectively. Co-localization of TLR4 and HIF-1α was detected by immunofluorescence staining and observed using fluorescence microscopy. Compared with the control group, cell proliferation was enhanced in the LPS-treated group and was not altered in the PDTC+LPS treatment group. Cell proliferation was reduced in all other treatment groups (P<0.05). Compared with the LPS group, cell proliferation decreased in all other groups. Compared with the PDTC+LPS treatment group, cell proliferation significantly decreased when LPS was co-administered with ST2825, siTLR4 and MβCD (P<0.01). Treatment with MβCD+LPS exhibited an increased inhibitory effect on cell activity and proliferation. Compared with the control group, HIF-1α expression was enhanced following treatment with LPS, although it decreased when LPS was co-administered with ST2825, siTLR4 and MβCD (P<0.05). HIF-1α expression decreased following treatment with ST2825, siTLR4, MβCD and PDTC+LPS, compared with treatment with LPS alone. Compared with the PDTC+LPS group, HIF-1α activity decreased when LPS was co-administered with ST2825, siTLR4 and MβCD. NADPH oxidase and ROS levels increased in cells treated with LPS, compared with the control group, at 24 and 12 h following treatment, respectively, and decreased at 12 h when LPS was co-administered with ST2825, siTLR4 and MβCD. There was no difference between the LPS and PDTC+LPS groups with respect to NADPH and ROS levels. Compared with the PDTC+LPS group, NADPH oxidase activity and ROS content decreased when LPS was co-administered with ST2825, siTLR4 and MβCD. NADPH oxidase activity and ROS content were lowest in the MβCD+LPS treatment group, and immunofluorescent staining demonstrated that TLR4 was localized to the cell surface and HIF-1α was primarily localized to the cytoplasm. TLR4 was co-expressed with HIF-1α in cervical cancer cells. The results of the present study suggested that TLR4 signaling primarily promoted HIF-1α activity via activation of lipid rafts/NADPH oxidase redox signaling and may be associated with the initiation and progression of cervical cancer. This promoting effect was stronger in TLR4/lipid rafts/NADPH oxidase pathway than that in TLR4-NF-κB signaling pathway. Therefore, the TLR4/lipid raft-associated redox signal may be a target for therapeutic intervention to prevent the growth of cervical cancer." @default.
• W2768609580 created "2017-12-04" @default.
• W2768609580 creator A5018826171 @default.
• W2768609580 creator A5021852513 @default.
• W2768609580 creator A5027526140 @default.
• W2768609580 creator A5029426756 @default.
• W2768609580 creator A5033856578 @default.
• W2768609580 creator A5066716873 @default.
• W2768609580 creator A5076153143 @default.
• W2768609580 creator A5079924199 @default.
• W2768609580 date "2017-11-20" @default.
• W2768609580 modified "2023-10-17" @default.
• W2768609580 title "TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in�vitro-implications for therapeutic intervention" @default.
• W2768609580 cites W1042878708 @default.
• W2768609580 cites W1540623547 @default.
• W2768609580 cites W1906027219 @default.
• W2768609580 cites W1915393172 @default.
• W2768609580 cites W1967184424 @default.
• W2768609580 cites W1972041876 @default.
• W2768609580 cites W1981322447 @default.
• W2768609580 cites W1983491691 @default.
• W2768609580 cites W1999276461 @default.
• W2768609580 cites W2000178052 @default.
• W2768609580 cites W2005427394 @default.
• W2768609580 cites W2011302177 @default.
• W2768609580 cites W2011810742 @default.
• W2768609580 cites W2016806021 @default.
• W2768609580 cites W2028986871 @default.
• W2768609580 cites W2031590299 @default.
• W2768609580 cites W2034277378 @default.
• W2768609580 cites W2041570796 @default.
• W2768609580 cites W2046648330 @default.
• W2768609580 cites W2046898357 @default.
• W2768609580 cites W2051133984 @default.
• W2768609580 cites W2056826548 @default.
• W2768609580 cites W2065186557 @default.
• W2768609580 cites W2071754972 @default.
• W2768609580 cites W2076987851 @default.
• W2768609580 cites W2085932611 @default.
• W2768609580 cites W2088535777 @default.
• W2768609580 cites W2094082272 @default.
• W2768609580 cites W2098312123 @default.
• W2768609580 cites W2100820852 @default.
• W2768609580 cites W2101499430 @default.
• W2768609580 cites W2124181587 @default.
• W2768609580 cites W2127700559 @default.
• W2768609580 cites W2142414417 @default.
• W2768609580 cites W2142548185 @default.
• W2768609580 cites W2149239890 @default.
• W2768609580 cites W2155725035 @default.
• W2768609580 cites W2167379393 @default.
• W2768609580 cites W2171295411 @default.
• W2768609580 cites W2178941970 @default.
• W2768609580 cites W2198429069 @default.
• W2768609580 cites W2261049552 @default.
• W2768609580 cites W2282341456 @default.
• W2768609580 cites W2396420191 @default.
• W2768609580 cites W2402130134 @default.
• W2768609580 cites W2406772038 @default.
• W2768609580 cites W2418603168 @default.
• W2768609580 cites W2488856326 @default.
• W2768609580 cites W2586153457 @default.
• W2768609580 cites W36446337 @default.
• W2768609580 doi "https://doi.org/10.3892/mmr.2017.8108" @default.
• W2768609580 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5783462" @default.
• W2768609580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29207048" @default.
• W2768609580 hasPublicationYear "2017" @default.
• W2768609580 type Work @default.
• W2768609580 sameAs 2768609580 @default.
• W2768609580 citedByCount "14" @default.
• W2768609580 countsByYear W27686095802018 @default.
• W2768609580 countsByYear W27686095802019 @default.
• W2768609580 countsByYear W27686095802020 @default.
• W2768609580 countsByYear W27686095802021 @default.
• W2768609580 countsByYear W27686095802022 @default.
• W2768609580 countsByYear W27686095802023 @default.
• W2768609580 crossrefType "journal-article" @default.
• W2768609580 hasAuthorship W2768609580A5018826171 @default.
• W2768609580 hasAuthorship W2768609580A5021852513 @default.
• W2768609580 hasAuthorship W2768609580A5027526140 @default.
• W2768609580 hasAuthorship W2768609580A5029426756 @default.
• W2768609580 hasAuthorship W2768609580A5033856578 @default.
• W2768609580 hasAuthorship W2768609580A5066716873 @default.
• W2768609580 hasAuthorship W2768609580A5076153143 @default.
• W2768609580 hasAuthorship W2768609580A5079924199 @default.
• W2768609580 hasBestOaLocation W27686095801 @default.
• W2768609580 hasConcept C1491633281 @default.
• W2768609580 hasConcept C153911025 @default.
• W2768609580 hasConcept C181199279 @default.
• W2768609580 hasConcept C185592680 @default.
• W2768609580 hasConcept C190283241 @default.
• W2768609580 hasConcept C2777527632 @default.
• W2768609580 hasConcept C2777989768 @default.
• W2768609580 hasConcept C2780783641 @default.
• W2768609580 hasConcept C38485361 @default.
• W2768609580 hasConcept C48349386 @default.
• W2768609580 hasConcept C55493867 @default.
• W2768609580 hasConcept C62112901 @default.
• W2768609580 hasConcept C86803240 @default.
• W2768609580 hasConceptScore W2768609580C1491633281 @default.

• next